Supplement encyclopedia

Biotin

Biotin is a water-soluble B vitamin (B7). It helps the body process fats, carbohydrates and amino acids. It is available on its own, in B-complex supplements and in multivitamins.

Double-check the conclusions and read the sources before choosing a supplement.

Main conclusion

Potential benefits

  • In confirmed biotin deficiency, replenishing biotin may help resolve the associated symptoms.
  • In a small study of adults with and without type 2 diabetes, 28 days of biotin use showed no convincing effect on fasting blood sugar, cholesterol, or triglycerides.
  • In adults with longstanding vision loss associated with multiple sclerosis, the biotin medicine MD1003 showed no convincing advantage over placebo in visual acuity over six months.

[1] [2] [3] [4]

What researchers studied

  • Biotin may distort the results of some laboratory tests, including thyroid hormone and troponin tests. Before testing, tell your doctor and the laboratory that you take biotin.
  • Biotin deficiency is rare. The risk is higher with inherited biotinidase deficiency, chronic alcohol use, and prolonged consumption of raw egg white.

[1] [2] [3] [4]

Forms studied

  • The vision study used the pharmaceutical product MD1003, providing 300 mg of biotin daily for six months.
  • The blood-marker study used 15 mg of biotin daily for 28 days.
  • Biotin may be listed on the package in milligrams or micrograms: 1 mg equals 1000 micrograms. The US reference intake for adults is 30 micrograms daily from all food and supplements.

[1] [2] [3] [4]

Food sources

  • An 85 g portion of cooked beef liver contains about 30.8 micrograms of biotin, and one whole cooked egg about 10 micrograms.
  • An 85 g portion of pink salmon canned in water contains about 5 micrograms of biotin, and the same serving of cooked pork chop 3.8 micrograms.
  • A quarter cup of roasted sunflower seeds provides about 2.6 micrograms, and half a cup of cooked sweet potato about 2.4 micrograms of biotin.

[1]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Change in visual acuity, logMARAt six months, visual acuity in the selected eye changed by −0.061 logMAR on MD1003 and −0.036 on placebo. On this scale, a decrease means better vision. The adjusted difference was −0.01983 (95% confidence interval −0.1085 to 0.0689; p=0.66). There was no convincing advantage over placebo.
3/4 ModerateRisk of bias. This randomized, double-blind trial used a pharmaceutical dose in people with optic nerve damage. The confidence interval was wide. The risk-of-bias assessment did not further lower confidence in the result. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The question concerns chronic vision loss in multiple sclerosis. The result cannot be extrapolated to healthy eyes. There was no additional downgrade for this domain. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.
11 publication describedMD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study ↗93 adults with chronic vision loss in multiple sclerosis: 65 on MD1003 and 28 on placebo. Participants had lasting effects of acute optic neuritis or progressive optic nerve damage.
  1. MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study ↗
Fasting glucoseOn day 28, mean fasting glucose in the biotin groups changed from 9.30 to 10.53 mmol/L in adults with type 2 diabetes and from 5.75 to 5.92 mmol/L in adults without diabetes. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.
1/4 Very lowRisk of bias: The randomized subgroups were very small. The corrected pharmaceutical dose and limited reporting narrow the applicability of the result. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The pharmaceutical dose or the characteristics of the population limit how far the result applies to consumer supplements. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.
11 publication describedEffects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗15 adults with type 2 diabetes (10 on biotin, 5 on placebo) and 12 without diabetes (7 on biotin, 5 on placebo)
  1. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗
  2. Erratum: Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗
Fasting cholesterol and triglyceridesOn day 28, mean fasting triglycerides in the biotin groups changed from 2.49 to 2.85 mmol/L in adults with type 2 diabetes and from 1.57 to 1.44 mmol/L in adults without diabetes. Total cholesterol changed from 5.05 to 5.16 and from 4.68 to 4.63 mmol/L, respectively. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.
1/4 Very lowRisk of bias: The individual groups were very small. The interpretation of subgroup comparisons is uncertain. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The pharmaceutical dose or the characteristics of the population limit how far the result applies to consumer supplements. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.
11 publication describedEffects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗15 adults with type 2 diabetes and 12 without diabetes, analyzed separately
  1. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗
  2. Erratum: Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

U.S. Adequate Intake for biotin from all foods and supplements
GroupAI, µg/day
Birth to 6 months5
7–12 months6
1–3 years8
4–8 years12
9–13 years20
14–18 years25
Adults aged 19 and older30
Pregnancy, ages 14–1830
Pregnancy, age 19 and older30
Breastfeeding, ages 14–1835
Breastfeeding, age 19 and older35

Biotin — Fact Sheet for Health Professionals ↗

Intake target, studied dose and upper limit
MeasureMeaning
AIA target for total intake. Evidence is insufficient to set an RDA.
2.5 mg/day in an observation of nail outcomes2,500 µg/day was the regimen studied. It is not a dietary requirement.
ULNo upper limit established. The risk of interference with lab tests is assessed separately.

Biotin — Fact Sheet for Health Professionals ↗

Forms

Biotin in supplements: Amounts are given in micrograms or milligrams: 1 mg = 1,000 µg and 5 mg = 5,000 µg. A high dose alone does not tell you what cosmetic effect, if any, to expect. Doses used in studies: The vision trial in multiple sclerosis used MD1003 at 300 mg/day. The small metabolic trial used 15 mg/day. This figure reflects the published 2007 correction.

Guidance for each goal

Change in visual acuity, logMAR3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateRisk of bias. This randomized, double-blind trial used a pharmaceutical dose in people with optic nerve damage. The confidence interval was wide. The risk-of-bias assessment did not further lower confidence in the result. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The question concerns chronic vision loss in multiple sclerosis. The result cannot be extrapolated to healthy eyes. There was no additional downgrade for this domain. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.

At six months, visual acuity in the selected eye changed by −0.061 logMAR on MD1003 and −0.036 on placebo. On this scale, a decrease means better vision. The adjusted difference was −0.01983 (95% confidence interval −0.1085 to 0.0689; p=0.66). There was no convincing advantage over placebo.

Study findings. At six months, visual acuity in the selected eye changed by −0.061 logMAR on MD1003 and −0.036 on placebo. On this scale, a decrease means better vision. The adjusted difference was −0.01983 (95% confidence interval −0.1085 to 0.0689; p=0.66). There was no convincing advantage over placebo.

Studied regimen300 mg/day of the pharmaceutical preparation MD1003Biotin
Duration and populationSix months93 adults with chronic vision loss in multiple sclerosis: 65 on MD1003 and 28 on placebo. Participants had lasting effects of acute optic neuritis or progressive optic nerve damage.

Comparator: Placebo

Fasting glucose1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The randomized subgroups were very small. The corrected pharmaceutical dose and limited reporting narrow the applicability of the result. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The pharmaceutical dose or the characteristics of the population limit how far the result applies to consumer supplements. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.

On day 28, mean fasting glucose in the biotin groups changed from 9.30 to 10.53 mmol/L in adults with type 2 diabetes and from 5.75 to 5.92 mmol/L in adults without diabetes. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.

Study findings. On day 28, mean fasting glucose in the biotin groups changed from 9.30 to 10.53 mmol/L in adults with type 2 diabetes and from 5.75 to 5.92 mmol/L in adults without diabetes. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.

Studied regimen15 mg/day (61.4 µmol/day according to the 2007 correction)Biotin
Duration and population28 days15 adults with type 2 diabetes (10 on biotin, 5 on placebo) and 12 without diabetes (7 on biotin, 5 on placebo)

Comparator: Placebo

Fasting cholesterol and triglycerides1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The individual groups were very small. The interpretation of subgroup comparisons is uncertain. Consistency: One direct trial covered this population and outcome, so consistency across studies could not be assessed. There was no additional downgrade for this domain. Applicability to the stated population: The pharmaceutical dose or the characteristics of the population limit how far the result applies to consumer supplements. Precision: The study was small or the confidence interval allows for materially different effects. Possible publication bias: Too few studies were available to assess publication bias reliably. There was no additional downgrade for this domain.

On day 28, mean fasting triglycerides in the biotin groups changed from 2.49 to 2.85 mmol/L in adults with type 2 diabetes and from 1.57 to 1.44 mmol/L in adults without diabetes. Total cholesterol changed from 5.05 to 5.16 and from 4.68 to 4.63 mmol/L, respectively. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.

Study findings. On day 28, mean fasting triglycerides in the biotin groups changed from 2.49 to 2.85 mmol/L in adults with type 2 diabetes and from 1.57 to 1.44 mmol/L in adults without diabetes. Total cholesterol changed from 5.05 to 5.16 and from 4.68 to 4.63 mmol/L, respectively. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.

Studied regimen15 mg/day (61.4 µmol/day according to the 2007 correction)Biotin
Duration and population28 days15 adults with type 2 diabetes and 12 without diabetes, analyzed separately

Comparator: Placebo

Safety and limitations

The U.S. Adequate Intake (AI) includes biotin from food and supplements combined. It is 30 µg/day for adults and during pregnancy, and 35 µg/day during breastfeeding. For children ages 1–3 it is 8 µg/day, ages 4–8 it is 12 µg/day, ages 9–13 it is 20 µg/day, and ages 14–18 it is 25 µg/day. It is a total intake target and does not determine the dose of a particular supplement or a safe upper limit. Deficiency is rare, and its signs can occur in other conditions. One milligram equals 1,000 µg, and 5 mg equals 5,000 µg. A high dose alone tells us nothing about benefits for hair, skin or nails. Evidence is insufficient to establish a tolerable upper intake level (UL). Biotin can interfere with lab results even when the person notices no side effects. When a deficiency is confirmed, correcting it may help resolve related symptoms. Inherited biotinidase deficiency requires specialist care. Biotinidase is an enzyme that helps the body use biotin. The cases described do not show how much hair, skin or nails would change in people without a deficiency. The risk of low biotin status is higher with biotinidase deficiency, chronic alcohol use and prolonged consumption of raw egg whites. Being in a risk group does not establish a diagnosis. In the multiple sclerosis vision study, relapses were reported in 9 of 65 participants taking 300 mg of biotin daily and in 1 of 28 participants on placebo. A link to biotin intake was not established. One participant developed a retinal artery blockage and did not continue in the study. The researchers considered a link to biotin possible. They also noted that biotin interfered with thyroid function tests.

Biotin — Fact Sheet for Health Professionals ↗ · Biotin Interference with Troponin Lab Tests — Assays Subject to Biotin Interference ↗ · Biotinidase Deficiency ↗ · MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study ↗

Interactions

WithEffectActionSource
Laboratory testsBiotin can falsely raise or lower results in some assays that use biotin–streptavidin binding. The FDA warns that troponin tests used when a heart attack is suspected may give falsely low results. Tell your clinician and the laboratory how much biotin you took and when. There is no universal interval for stopping it before testing.Tell your clinician and the laboratory the dose and when you took it. The length of the pause before testing depends on the test. There is no universal interval.Biotin — Fact Sheet for Health Professionals ↗
Antiseizure medicinesLong-term use of some antiseizure medicines is associated with lower biotin status. This does not mean everyone needs a supplement. Do not change prescribed treatment on your own.Do not change prescribed antiseizure treatment on your own. The need for a supplement is assessed individually.Biotin — Fact Sheet for Health Professionals ↗

Food sources

Food composition

FoodGroupAmountServingCaloriesSources
Beef liverCookedOrgan meats—30.8 µg of biotin per 85 g (3 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
EggWhole, cookedEggs—10 µg of biotin per egg, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
Pink salmonCanned in waterFish—5 µg of biotin per 85 g (3 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
PorkCooked chopMeat—3.8 µg of biotin per 85 g (3 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
Beef pattyCookedMeat—3.8 µg of biotin per 85 g (3 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
Sunflower seedsRoastedNuts and seeds—2.6 µg of biotin per quarter cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
Sweet potatoCookedVegetables—2.4 µg of biotin per half cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
AlmondsRoastedNuts and seeds—1.5 µg of biotin per quarter cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
TunaCanned in waterFish—0.6 µg of biotin per 85 g (3 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
SpinachBoiledLeafy greens—0.5 µg of biotin per half cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
BroccoliFreshVegetables—0.4 µg of biotin per half cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
CheddarMildDairy products—0.4 µg of biotin per 28 g (1 oz), using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
2% milkReady to consumeDairy products—0.3 µg of biotin per cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
Plain yogurtReady to consumeDairy products—0.2 µg of biotin per cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗
OatmealCookedGrains—0.2 µg of biotin per cup, using the NIH value for this serving.——Biotin — Fact Sheet for Health Professionals ↗

Biotin — Fact Sheet for Health Professionals ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study ↗Change in visual acuity, logMAR93 adults with chronic vision loss in multiple sclerosis: 65 on MD1003 and 28 on placebo. Participants had lasting effects of acute optic neuritis or progressive optic nerve damage.Biotin, 300 mg/day of the pharmaceutical preparation MD1003, for six months. Comparator: placebo.At six months, visual acuity in the selected eye changed by −0.061 logMAR on MD1003 and −0.036 on placebo. On this scale, a decrease means better vision. The adjusted difference was −0.01983 (95% confidence interval −0.1085 to 0.0689; p=0.66). There was no convincing advantage over placebo.
Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects ↗Fasting glucose: Fasting glucose Fasting cholesterol and triglycerides: Fasting cholesterol and triglyceridesFasting glucose: 15 adults with type 2 diabetes (10 on biotin, 5 on placebo) and 12 without diabetes (7 on biotin, 5 on placebo) Fasting cholesterol and triglycerides: 15 adults with type 2 diabetes and 12 without diabetes, analyzed separatelyFasting glucose: Biotin, 15 mg/day (61.4 µmol/day according to the 2007 correction), for 28 days. Comparator: placebo. Fasting cholesterol and triglycerides: Biotin, 15 mg/day (61.4 µmol/day according to the 2007 correction), for 28 days. Comparator: placebo.Fasting glucose: On day 28, mean fasting glucose in the biotin groups changed from 9.30 to 10.53 mmol/L in adults with type 2 diabetes and from 5.75 to 5.92 mmol/L in adults without diabetes. In their three-factor analysis, the authors found no statistically significant effect of biotin intake. Fasting cholesterol and triglycerides: On day 28, mean fasting triglycerides in the biotin groups changed from 2.49 to 2.85 mmol/L in adults with type 2 diabetes and from 1.57 to 1.44 mmol/L in adults without diabetes. Total cholesterol changed from 5.05 to 5.16 and from 4.68 to 4.63 mmol/L, respectively. In their three-factor analysis, the authors found no statistically significant effect of biotin intake.